Easywell Biomedical (1799)

Currency in TWD
46.65
+0.60(+1.30%)
Closed·
1799 Scorecard
Full Analysis
Prominent player in the Pharmaceuticals industry
1799 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
45.3547.10
52 wk Range
42.45233.00
Key Statistics
Bid/Ask
16.10 / 16.15
Prev. Close
67.5
Open
45.95
Day's Range
45.35-47.1
52 wk Range
42.45-233
Volume
163.04K
Average Volume (3m)
157.91K
1-Year Change
-75.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1799 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Easywell Biomedical Company Profile

Easywell Biomedicals, Inc., together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in America. It operates through Drug Development and Other segments. The company develops TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; TLX-011 for treatment of inflammatory lesions of rosacea; TLX-015 a prevention and treatment medicine for postpartum hemorrhage; TLX-018, a hemorrhage treatment drug; TLX-030, an anti-inflammatory medicine; and TLX-024, an anticonvulsant. It also develops TWB-201 for Parkinson patch; TLX-501, a urinary medicine; and TLX-502, a pneumonia medicine. In addition, the company provides thermometers, medical devices, and health food and products. It has a collaborative development agreement with Handa Pharmaceuticals and Handa Neuroscience, LLC for the development of TLX-050 for the treatment of neurological disorders. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.

0
Market
Taiwan

Compare 1799 to Peers and Sector

Metrics to compare
1799
Peers
Sector
Relationship
P/E Ratio
−115.0x−202.0x−0.5x
PEG Ratio
−1.71−2.260.00
Price/Book
7.8x6.2x2.6x
Price / LTM Sales
9.3x9.8x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock−11.9%6.8%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
151.54M / --
EPS Revisions
Last 90 days

1799 Income Statement

FAQ

What Stock Exchange Does Easywell Biomedical Trade On?

Easywell Biomedical is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for Easywell Biomedical?

The stock symbol for Easywell Biomedical is "1799."

What Is the Easywell Biomedical Market Cap?

As of today, Easywell Biomedical market cap is 5.82B.

What Is Easywell Biomedical's Earnings Per Share (TTM)?

The Easywell Biomedical EPS (TTM) is -0.41.

From a Technical Analysis Perspective, Is 1799 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Easywell Biomedical Stock Split?

Easywell Biomedical has split 7 times.

How Many Employees Does Easywell Biomedical Have?

Easywell Biomedical has 0 employees.

What is the current trading status of Easywell Biomedical (1799)?

As of 09 Aug 2025, Easywell Biomedical (1799) is trading at a price of 46.65, with a previous close of 67.50. The stock has fluctuated within a day range of 45.35 to 47.10, while its 52-week range spans from 42.45 to 233.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.